1 / 8

Aims:

Discussant Slides: Title: Radiosensitivity Index Shows Promise for Predicting Outcomes with Adjuvant Radiation in Resected Pancreatic Cancer Patients Poster #: Monitor 4 Author: Ravi Shridhar MD, PhD.

jraquel
Download Presentation

Aims:

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Discussant Slides: Title: Radiosensitivity Index Shows Promise for Predicting Outcomes with Adjuvant Radiation in Resected Pancreatic Cancer PatientsPoster #: Monitor 4Author: Ravi Shridhar MD, PhD

  2. Title: Index Shows Promise for Predicting Outcomes with Adjuvant Radiation in Resected Pancreatic Cancer PatientsPoster #: Monitor 4Author: Ravi Shridhar MD, PhD • Aims: • To compare intrinsic radiosensitivity of pancreatic cancers to other tumor types utilizing a novel 10 gene radiation specific biomarker that derives a radiosensitivity score (RSI) • To determine if RSI is prognostic for overall survival in resected pancreatic cancer

  3. Title: Radiosensitivity Index Shows Promise for Predicting Outcomes with Adjuvant Radiation in Resected Pancreatic Cancer PatientsPoster #: Monitor 4Author: Ravi Shridhar MD, PhD • Methods: • RSI score was calculated from a deidentified pool of 13261 genomically-profiled tumor specimens (Affymetrix Hu-RSTA-2a520709) from our Total Cancer Care Program (2006-2010) • RSI scores from 452 pancreatic cancer specimens were compared against the rest • From our tumor registry, we identified 251 resected pancreatic adenocarcinomas, of which 80 patients (49 who received postop CRT) had profiles from which we could derive RSI scores • From this dataset, a median RSI score was calculated and used a cutpointto determine prognosis

  4. Title: Radiosensitivity Index Shows Promise for Predicting Outcomes with Adjuvant Radiation in Resected Pancreatic Cancer PatientsPoster #: Monitor 4Author: Ravi Shridhar MD, PhD

  5. Title: Radiosensitivity Index Shows Promise for Predicting Outcomes with Adjuvant Radiation in Resected Pancreatic Cancer PatientsPoster #: Monitor 4Author: Ravi Shridhar MD, PhD • Results • Pancreatic cancer was more radioresistant than other cancers based on RSI P<0.0001 PDF – probability density function

  6. Title: Radiosensitivity Index Shows Promise for Predicting Outcomes with Adjuvant Radiation in Resected Pancreatic Cancer PatientsPoster #: Monitor 4Author: Ravi Shridhar MD, PhD • Results • We defined • High risk (HR) (R1, N1, and postop CA19-9>90) • Low risk (LR) (R0, N0, postop CA19-9<90) • RSI high = Radioresistant (RR) • RSI low = Radiosensitive (RS) • HR patient had worse OS (hazard ratio 4.4: 1.8-11.1; p=0.001) compared to LR. • In HR radiated pts, 3y OS for RS vs RS was 38% vs 8% (p=0.07). RSI was not prognostic in unirridiated pts (p=0.79). • Integrating RSI into risk stratification to define intermediate risk (IR) • No difference in OS between HR-RS vs LR-RR (3y OS 38% vs 50%; p=0.29). • RSI adds significant prognostic value to the risk stratification defined in this analysis (Figure 2, Table 1).

  7. Title: Radiosensitivity Index Shows Promise for Predicting Outcomes with Adjuvant Radiation in Resected Pancreatic Cancer PatientsPoster #: Monitor 4Author: Ravi Shridhar MD, PhD • Results

  8. Title: Radiosensitivity Index Shows Promise for Predicting Outcomes with Adjuvant Radiation in Resected Pancreatic Cancer PatientsPoster #: Monitor 4Author: Ravi Shridhar MD, PhD • Results P=0.001

More Related